Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193805-22-001022
Filing Date
2022-06-27
Accepted
2022-06-27 19:16:04
Documents
1
Period of Report
2022-06-23

Document Format Files

Seq Description Document Type Size
1 e621783_4-jing.html 4  
1 e621783_4-jing.xml 4 3977
  Complete submission text file 0001193805-22-001022.txt   5381
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121 8589002660
Arcturus Therapeutics Holdings Inc. (Issuer) CIK: 0001768224 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O KRYSTAL BIOTECH, INC. 2100 WHARTON STREET, SUITE 701 PITTSBURGH PA 15203
Business Address
Marantz Jing L. (Reporting) CIK: 0001834528 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38942 | Film No.: 221046116